Stereotaxis Inc  

(Public, NASDAQ:STXS)   Watch this stock  
Find more results for Fred Mills
-0.01 (-0.96%)
Nov 25 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.00 - 1.08
52 week 0.65 - 2.97
Open 1.03
Vol / Avg. 136,892.00/87,716.00
Mkt cap 22.62M
P/E     -
Div/yield     -
EPS -0.23
Shares 21.54M
Beta 3.00
Inst. own 29%
Feb 23, 2016
Q4 2015 Stereotaxis Inc Earnings Release (Estimated) Add to calendar
Nov 3, 2015
Q3 2015 Stereotaxis Inc Earnings Call - Webcast
Nov 3, 2015
Q3 2015 Stereotaxis Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -10.75% -14.86%
Operating margin -9.78% -15.38%
EBITD margin - -13.34%
Return on average assets -20.73% -18.93%
Return on average equity - -
Employees 133 -
CDP Score - -


4320 Forest Park Ave Ste 100
ST. LOUIS, MO 63108-2979
United States - Map
+1-314-6786100 (Phone)
+1-314-6786159 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Stereotaxis, Inc. (Stereotaxis) designs, manufactures and markets robotic systems and instruments for use primarily by electrophysiologists for the treatment of abnormal heart rhythms known as cardiac arrhythmias. The Company offers its Epoch Solution, a remote robotic navigation system for use in a hospital's interventional surgical suite or interventional lab. The Epoch Solution consists of the Niobe ES Robotic Magnetic Navigation System (Niobe ES system), Odyssey Information Management Solution (Odyssey Solution) and the Vdrive Robotic Navigation System (Vdrive system). The components of the Niobe system include Niobe Remote Magnetic Navigation System and Cardiodrive Automated Catheter Advancement System. The Odyssey Solution offers a real-time information solution to manage, control, record and share procedures across networks or around the world. The Vdrive system provides navigation and stability for diagnostic and ablation devices.

Officers and directors

William C. Mills III Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Martin C. Stammer Chief Financial Officer, IR Contact Officer
Age: 34
Bio & Compensation  - Reuters
Karen W. Duros Senior Vice President, General Counsel, Secretary
Age: 60
Bio & Compensation  - Reuters
Frank J. Cheng Senior Vice President - Marketing and Business Development
Age: 47
Bio & Compensation  - Reuters
David A. Giffin Vice President - Human Resources
Age: 66
Bio & Compensation  - Reuters
Duane M. DeSisto Director
Age: 60
Bio & Compensation  - Reuters
David W. Benfer Independent Director
Age: 68
Bio & Compensation  - Reuters
Joseph D. Keegan Ph.D. Independent Director
Age: 61
Bio & Compensation  - Reuters
Robert J. Messey Independent Director
Age: 69
Bio & Compensation  - Reuters
Fred A. Middleton Independent Director
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance